Speaker illustration

Ms Anina Fraschke

Bayer AG, Berlin (Germany)

In her role as global HEOR project lead Anina develops healtheconomic tools and analyses to facilitate and maintain patient access to new cardiovascular medications. During almost 20 years in the pharmaceutical industry she has worked in several therapy areas such as cardiology, oncology, hemophilia and MS and gained vast experience on the Scandinavian HTA and market access processes. Anina holds a Master's degree in Economical Mathematics from the University of Ulm, Germany. Her special interest is the field of Real World Evidence.

Heart failure in France- insights from a cohort of french heart failure patients using claims data

Event: Heart Failure 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Heart Failure – Epidemiology, Prognosis, Outcome


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb